Literature DB >> 1011334

The cost of upper respiratory tract infections in Canadian children.

C P Shah, M L Chipman, L D Pizzarello.   

Abstract

We reviewed reports of the incidence, duration, causative organism, sequelae, and cost of upper respiratory tract infections (URI). Using these data, we projected the extent and cost of URI in Canadian children from birth to age 14. We estimated that in 1973, some 6.2 million Canadian children suffered between 23.8 and 42.3 million episodes of URI, of which 5.6 million needed medical attention; approximately 215,300 children were admitted to hospital for treatment of URI-related diseases and utilized 742,800 hospital days. Some direct costs were estimated, including physicians' fees, hospitalization, antibiotics, "cold remedies", and pharmacists' prescription fees; in 1973 these ranged from $141 million to $211 million. The common cold is as common as its name implies, and we need to intensify the search for a solution. Until this is found, both medical profession and the public should be warned of the uselessness, and possible hazards of some of the "remedies" for colds, and made aware of the vast amounts of money expended upon them.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1011334

Source DB:  PubMed          Journal:  J Otolaryngol        ISSN: 0381-6605


  5 in total

1.  Day-care surgery in British Columbia: a 7-year experience (1968-74).

Authors:  C P Shah; G C Robinson
Journal:  Can Med Assoc J       Date:  1977-05-07       Impact factor: 8.262

2.  A manual acupuncture treatment attenuates common cold and its symptoms: a case series report from South Korea.

Authors:  Je-Sin Heo; Su-Young Yang; Sung-Ah Lim; Jong-Moo Lee; Ji-Young Kang; Seung-Ho Sun; Hyeong-Geug Kim; Weechang Kang; Jung-Hyo Cho
Journal:  J Tradit Chin Med       Date:  2016-12       Impact factor: 0.848

3.  Do Japanese style acupuncture and moxibustion reduce symptoms of the common cold?

Authors:  Kenji Kawakita; Toshiyuki Shichidou; Etsuko Inoue; Tomoyuki Nabeta; Hiroshi Kitakoji; Shigekatsu Aizawa; Atsushi Nishida; Nobuo Yamaguchi; Norihito Takahashi; Eiji Sumiya; Kaoru Okada; Takashi Umeda; Tadashi Yano; Shouhachi Tanzawa
Journal:  Evid Based Complement Alternat Med       Date:  2007-06-11       Impact factor: 2.629

Review 4.  The common cold.

Authors:  G B Stickler; T F Smith; D D Broughton
Journal:  Eur J Pediatr       Date:  1985-05       Impact factor: 3.183

5.  Cost of inappropriate antimicrobial use for upper respiratory infection in Japan.

Authors:  Shinya Tsuzuki; Yuki Kimura; Masahiro Ishikane; Yoshiki Kusama; Norio Ohmagari
Journal:  BMC Health Serv Res       Date:  2020-02-28       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.